Supplement safety by Maffei, M.
Professor Massimo Maffei outlines how prevailing 
misconceptions regarding dietary supplements can 
be harmful for consumers and how companies like 
Biosfered Ltd are helping to facilitate informed decisions
Can you outline your background and what 
led to your research on dietary supplements?
I am a plant physiologist and have studied 
secondary plant products since 1987 when 
I undertook postdoctoral research at 
Washington State University’s Institute of 
Biological Chemistry in the US. My fields 
of expertise are terpenoids and phenolics, 
which I research using various different 
methodologies, from analytical chemistry/
biochemistry to molecular biology. 
I entered the world of dietary supplements in 
1998, when – as an expert in plant bioactive 
compounds – I was invited by the Office of 
Dietary Supplements (ODS) of the National 
Institutes of Health (NIH) to take part in a 
survey on the main US institutions involved 
in functional foods studies. 
How would you define a dietary 
supplement? Why have these products 
become so widely used in recent years?
There are many definitions, but I think 
that the ODS’ definition is the most 
complete: any substance that is consumed 
in addition to the regular diet, excluding 
food items that are intended to be a sole 
source of nutrition, meal replacements or 
conventional foods. Dietary supplements are 
intended to supplement 
the common diet 
and are usually 
concentrated sources 
of nutrients. These 
commonly include 
vitamins and minerals, 
or other substances 
with a nutritional or 
physiological effect, in particular 
but not limited to amino acids, essential 
fatty acids, fibre and extracts of plant origin. 
Perceptions that dietary supplements are 
natural and safe and may prevent disease, 
replace prescription medicines or make up 
for a poor diet have played an important 
role in their increased use.
Why are dietary supplements less safe to 
consume than is widely believed?
The majority of dietary supplements on 
the market pass the regulatory checks of 
country’s authorities and are therefore 
to be considered safe. Consumers should 
always check the products they buy for the 
authorisation that puts them on the market. 
In order to be safe and physiologically 
useful, dietary supplements must be used in 
a conscious and informed way, considering 
their function and their properties, without 
coming into conflict with the preservation 
of eating habits and appropriate behaviour 
as part of a healthy way of life. Since 
their use is generally without medical 
supervision, it is essential to consider 
that potential problems due to herb-
drug interactions – pharmacokinetic and 
pharmacodynamic – may arise.
You have highlighted some of the threats 
posed by misuse of these products – could 
you elaborate on these dangers?
In general, fewer and less rigorous studies 
are available for dietary supplements than 
for prescription drugs, particularly with 
respect to randomised controlled clinical 
trials. Future herb-drug interaction studies 
should be carried out to determine whether 
herbal supplements can potentially affect 
the pharmacokinetics and the efficacy or 
safety of chemotherapeutic agents.
How does your work seek to overcome 
some of the most common issues faced by 
this industry?
We recently created an academic spin-
off (Biosfered Ltd) that aims to join the 
scientific expertise of our group and the 
capability to isolate and characterise 
bioactive compounds with industrial 
processes, through patented techniques 
and technologies based on green chemistry 
that do not involve the use of toxic solvents. 
The products are chemically characterised 
and titrated via advanced analytical and 
spectrometric techniques. This strategy 
aims to stimulate other SMEs embarking 
on the journey towards the chemical 
characterisation and quantification of 
bioactive compounds.
Your research requires you to work 
alongside industry. Are there ever any 
conflicting interests? 
The role of research centres and 
universities is to provide the basic and 
applied science needed to develop 
methods and strategies for correct 
technology transfer to industry. The 
creation of academic spin-offs makes this 
transfer easier and faster, bringing together 
two worlds that often revolve around the 
same issue: improving quality of life. SMEs 
are often too small to afford the analytical 
technology that may boost their products, 
so the support of research centres and 
universities may represent the turning 
point to increase their visibility and profits.
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Confusing data
Concerns over the quality of dietary supplements have called into 
question the regulations surrounding their manufacture. Now, research 
at the University of Turin is demonstrating how forging links between 
universities and SMEs can vastly improve consumer safety
Furanoeudesma-1,3-diene: a typical myrrh  
bioactive furanodiene.
MARKETED AS ‘NATURAL’ products, dietary 
supplements are widely perceived as safe agents 
with nutritional benefits, able to help prevent 
disease and even serve as replacements for 
prescription medicine. More and more, people are 
using dietary supplements as part of their daily 
routine. They are even becoming popular among 
patients suffering serious diseases, such as cancer. 
It is estimated that one person in five uses them in 
addition to their prescribed medicine, but natural 
does not always mean safe. 
Defined as any orally administered non-food, 
non-drug product containing at least one 
dietary ingredient, such as vitamins or minerals, 
the widespread use of dietary supplements 
is unencumbered by medical supervision and 
sometimes rife with misleading labelling of the 
products themselves. Concerns over excessive 
intake of vitamins and minerals has led the 
European Food Safety Authority (EFSA) to set 
up a framework to ensure responsible labelling 
of a product’s contents so that consumers can 
make more informed decisions about their 
purchases. However, a significant challenge 
exists in completely characterising the bioactive 
compounds in raw plant materials with the 
tools commonly used by manufacturers. 
Addressing this technological gap, research at 
the University of Turin in Italy aims to help SMEs 
in the dietary supplement market by ushering 
in a new generation of analytical methods for 
standardisation and the accurate quantification 
of plant bioactive compounds.
ADVANCING THE INDUSTRY
At the heart of this marriage between 
industry and basic research is Massimo 
Maffei, Professor of Plant Physiology at the 
University’s Department of Life Sciences 
and Systems Biology since 2000. In 
addition to coordinating the PhD School of 
Pharmaceutical and Biomolecular Sciences 
and serving as Editor-in-Chief of the open-
access Journal of Plant Interactions, Maffei 
co-founded the academic spin-off Biosfered 
Ltd in 2013, in which he acts as the company’s 
Director of Research and Development. 
Here, Maffei’s efforts to develop advanced 
characterisation and mining tools leave the 
world of basic research to meet industry, 
as they are applied to produce bioactive 
molecules with high commercial value.
Although there are strict regulations for 
marketing dietary supplements in the EU and 
the US, too many SMEs lack the funds to acquire 
the tools needed for more complete analysis of 
plant raw materials. The two most commonly 
used methods are hydrogen-1 nuclear magnetic 
resonance (1H NMR) spectroscopy and mass 
spectrometry (MS). With a greater threshold 
for detecting metabolites, MS is a more 
sensitive method for characterising bioactive 
ingredients than 1H NMR spectroscopy, but 
surveys show that metabolomic research tends 
to favour the more insensitive approach of NMR 
spectroscopy. Without the aid of more advanced 
analytical techniques for quantification and 
standardisation, enterprises involved in the 
business of dietary supplements are prone to 
miss out the finer details of plant extracts; it 
only takes one of a variety of factors to induce 
changes in the composition and contents of 
their active constituents. Between temperature, 
climate, humidity, season, soil conditions and 
various other circumstances, there can be a 
great deal of variance amongst specimens 
that are not accounted for by the simple use 
of spectrophotometers and low-resolution 
separation techniques. Hence, by joining forces 
with labs like Maffei’s, manufacturers without the 
means to do so on their own stand a far greater 
chance of meeting required quality standards. 
CUTTING-EDGE CHARACTERISATION
Helping to ensure the validity of manufacturers’ 
claims and improve consumer safety, Maffei’s 
lab uses state-of-the-art methods for the 
identification and separation of bioactive 
compounds from plant extracts. MS and 
NMR approaches are still vital tools in the 
research arsenal, but it is the compound of 
interest that dictates the methods employed. 
Among these cutting-edge processes are high-
performance liquid chromatography (HPLC), 
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It is estimated that one person 
in five uses dietary supplements 
in addition to their prescribed 
medicine, but natural does not 
always mean safe
Myrrh resin-gum: a raw material full of  
bioactive compounds.
capillary electrophoresis (CE), both gas and 
liquid chromatography (GC, LC) and diode 
array detectors (DAD). In combination, these 
methods can become powerful instruments for 
generating chromatogram and spectrum ‘two-
way data’, thereby revealing a great deal more 
about the identities of known and unknown 
chemical compounds. 
Exploiting DAD and MS as identification 
methods and the separation facility of 
chromatography, hyphenated combinations 
of HPLC-DAD-MS instruments are a vital 
approach employed by Maffei for the analysis of 
non-volatile compounds. Using GC to initially 
separate the volatile organic compounds, 
quantitative determination is then enabled 
via MS or flame ionisation detection (FID). 
In a tandem MS (MS/MS) approach that also 
utilises electrospray ionisation (ESI), Maffei can 
then analyse the non-volatile compounds using 
HPLC-DAD-ESI-MS/MS. 
However, there is always room for improvement; 
recently, plans have been made to purchase 
two instruments: one for ultrahigh performance 
liquid chromatography-quadrupole time of flight 
(UHPLC-qTOF) and another for comprehensive 
two-dimensional gas chromatography-
quadrupole time of flight (GCXGX-qTOF). 
Due to the sensitivity, high mass accuracy and 
rapidity of data acquisition they afford, time 
of flight machines will allow for even greater 
characterisation of both known and unknown 
bioactive compounds in plant extracts.
CONTENT CONFUSION
Metabolomics and chemometrics are 
certainly providing the best analyses of raw 
plant materials available, but without more 
stringent labelling rules consumers are often 
unaware of the realities of the information 
they are presented with. Some companies 
label the contents of bioactive compounds 
in their dietary supplement products as a 
percentage value while others express the 
contents in mg per serving or mg per gram 
of the final product. It is not always clear, 
however, whether the percentage refers to 
the chemical analysis or the final weight of the 
product and is misleading for both consumers 
and producers. 
To illustrate this, Maffei takes the preparation 
of Commiphora myrrha (myrrh) as an example. 
Myrrh’s biological activity is based on its 
content of furanodienes; expressed as a 
percentage, the consumer naturally assumes 
that it refers to the percentage of furanodienes 
for every kg of myrrh, which it does not. In 
actuality, the percentage indicates the total 
amount of volatile compounds in the extract 
analysed by GC, but there are plenty of 
other compounds that are not found in the 
volatile fraction. In order to reflect the true 
concentration, Maffei believes that producers 
could use an internal standard in the analytical 
process with which to quantify the compound 
and express it in mg/g or kg of the end product. 
TRANSPARENCY
Presenting consumers with clearly labelled 
information is a critical step to give a rationale 
for the use of dietary supplements. Advanced 
methods of separation, identification and 
quantification, obtained with the support 
of universities and academic spin-offs 
like Biosfered Ltd, will enable producers 
in many countries to acquire the highest 
quality raw-materials to make products that 
meet international safety standards such 
as those followed in the EU and US. Some 
current regulations are looking ever more 
outdated, as it is increasingly clear that 
simple spectrophotometer and low-resolution 
separation methods cannot sufficiently ensure 
high-quality produce or consumer safety. 
Maffei is confident that with the increased use 
of advanced analytical instruments, regulatory 
bodies will have to change their protocols in 
line with growing global awareness on the risks 
and benefits of dietary supplements.
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plant metabolomics and transcriptomics of 
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conditions. Specifically, the aim is to provide 
SMEs with sound and certified technologies 
and methodologies for the quantitative 
determination of bioactive compounds in 
raw materials used for the preparation of 
dietary supplements.
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